Impact of mitomycin C on the mRNA expression signatures of immunological biomarkers in eosinophilic nasal polyposis

American Journal of Rhinology and Allergy

Volumn 27, Issue 1, 2013, Pages

  De Castro, Mirian Cabral Moreira ^a   Rocha Silva, Fabiana ^b   Gomes, Luciana Inácia ^b   Zauli, Danielle Alves Gomes ^b   De Moraes Mourao, Marina ^b   De Castro, Mariana Moreira ^a   Guimaraes, Roberto Eustáquio Santos ^a   Teixeira Carvalho, Andrea ^b   Martins Filho, Olindo Assis ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 2; EOTAXIN 2; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; MITOMYCIN; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHILIC NASAL POLYPOSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MAXILLARY SINUS; NOSE MUCOSA; NOSE POLYP; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADMINISTRATION, TOPICAL; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; CELL MOVEMENT; COMPLEMENTARY THERAPIES; CYTOKINES; EOSINOPHILS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-3; MITOMYCIN; NASAL MUCOSA; NASAL POLYPS; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84876030337     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3868     Document Type: Article

References (37)

1. Bachert C, Gevaert P, Holtappels G, et al. Nasal polyposis: From cytokines to growth. Am J Rhinol 14:279-290, 2000.
2. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 131(suppl 6):S1-S62, 2004.
3. Newton JR, and Ah-See KW. A review of nasal polyposis. Therapeutics and clinical. Risk Manag 4:507-512, 2008.
4. Devars du Mayne M, Prulière-Escabasse V, Zerah-Lancner F, et al. Polypectomy compared with ethmoidectomy in the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg 137:111-117, 2011.
5. Fokkens W, Lund V, and Mullol J. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 45:97-101, 2007.
6. Rinia AB, Kostamo K, Ebbens FA, et al. Nasal polyposis: A cellularbased approach to answering questions. Allergy 62:348-358, 2007.
7. Ingrams DR, Volk MS, Biesman BS, et al. Sinus surgery: Does mitomycin C reduce stenosis? Laryngoscope 108:883-886, 1998.
8. Penttilǎ E, Smirnov G, Seppǎ J, et al. Mitomycin C in revision endoscopic dacryocystorhinostomy: A prospective randomized study. Am J Rhinol Allergy 25:425-428, 2011.
9. Chung JH, Cosenza MJ, Rahbar R, and Metson RB. Mitomycin C for the prevention of adhesion formation after endoscopic sinus surgery: A randomized, controlled study. Otolaryngol Head Neck Surg 126: 468-474, 2002.
10. Tabaee A, Brown SM, and Anand VK. Mitomycin C and endoscopic sinus surgery: Where are we? Curr Opin Otolaryngol Head Neck Surg 15:40-43, 2007.
11. de Castro MC, Assunçǎo E, de Castro MM, et al. Effect of mitomycin C in eosinophilic nasal polyposis, in vivo: Concentration of IL5 and GM-CSF, RT-PCR. Braz J Otorhinolaryngol 72:38-42, 2006.
12. Abraham LM, Selva D, Casson R, and Leibovitch I. Mitomycin: Clinical applications in ophthalmic practice. Drugs 66:321-340, 2006.
13. Estrem SA, and Vanleeuwen RN. Use of mitomycin C for maintaining myringotomy patency. Otolaryngol Head Neck Surg 122:8-10, 2000.
14. Crosara PF, Vasconcelos AC, Guimarǎes RE, et al. Effect of mitomycin C on the secretion of granulocyte macrophages colonies stimulating factor and interleukin-5 in eosinophilic nasal polyps stromal culture. Braz J Otorhinolaryngol 71:459-463, 2005.
15. Hlavin EM, Smeaton MB, and Miller PS. Initiation of DNA interstrand cross-link repair in mammalian cells. Environ Mol Mutagen 51:604-624, 2010.
16. Crosara PFTB, Nascimento E, Sobrinho SC, et al. Effect of mitomicin C in eosinofilic nasal polyps estromal culture: Induction of apoptosis in eosinophil. Rev Bras Otorrinolaringol 70:658-663, 2004.
17. Ingels K, Durdurez JP, Cuvelier C, and van Cauwenberge P. Nasal biopsy is superior to nasal smear for finding eosinophils in nonallergic rhinitis. Allergy 52:338-341, 1997.
18. Boeuf P, Vigan-Womas I, Jublot D, et al. CyProQuant-PCR: A real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol 6:1-14, 2005.
19. Vernal R, Leon R, Herrera D, et al. Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans. J Periodontal Res 43:689-697, 2008.
20. Overbergh L, Giulietti A, Valckx D, et al. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14:33-43, 2003.
21. Schulbin H, Bode H, Stocker H, et al. Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy. Antimicrob Agents Chemother 52:3377-3384, 2008.
22. Cheadle EJ, Riyad K, Subar D, et al. Eotaxin-2 and colorectal cancer: A potential target for immune therapy. Clin Cancer Res 13:5719-5728, 2007.
23. Valera FC, Queiroz R, Scrideli C, et al. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clin Exp Allergy 39:81-88, 2009.
24. Musso O, Sommer P, Drouet E, et al. In situ detection of human cytomegalovirus DNA in gastrointestinal biopsies from AIDS patients by means of various PCR-derived methods. J Virol Methods 56:125-137, 1996.
25. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622, 2009.
26. Livak KJ, and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408, 2001.
27. Luiza-Silva M, Campi-Azevedo AC, Batista MA, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis 204:873-883, 2011.
28. Ramanathan M Jr, Lee WK, Spannhake EW, and Lane AP. Th2 cytokines associated with chronic rhinosinusitis with polyps downregulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol 22:115-121, 2008.
29. Lezcano-Meza D, Da'vila-Da'vila B, Vega-Miranda A, et al. Interleukin (IL)-4 and to a lesser extent either IL-13 or interferon-gamma regulate the production of eotaxin-2/CCL24 in nasal polyps. Allergy 58:1011- 1017, 2003.
30. Schaefer D, Meyer JE, Pods R, et al. Endothelial and epithelial expression of eotaxin-2 (CCL24) in nasal polyps. Int Arch Allergy Immunol 140:205-214, 2006.
31. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61: 1280-1289, 2006.
32. Daines SM, and Orlandi RR. Inflammatory cytokines in allergy and rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 18:187-190, 2010.
33. Otto BA, and Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg 16:270-274, 2008.
34. Rostkowska-Nadolska B, Kapral M, Mazurek U, et al. Co-expression of the TGF-beta1 and TGF- beta2 isoforms in nasal polyps and in healthy mucosa. Postepy Hig Med Dosw 61:702-707, 2007.
35. Badia L, and Lund V. Topical corticosteroids in nasal polyposis. Drugs 61:573-578, 2001.
36. Mygind N, Dahl R, and Bachert C. Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax 55(suppl 2):S79-S83, 2000.
37. Chou SF, Chang SW, and Chuang JL. Mitomycin C upregulates IL-8 and MCP-1 chemokine expression via mitogen-activated protein kinases in corneal fibroblasts. Invest Ophthalmol Vis Sci 48:2009-2016, 2007.